
Arbitel Trio 25 Tablet ER 15s
In Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
People who purchased Arbitel Trio 25 Tablet ER 15s also bought
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Arbitel Trio 25 Tablet ER 15s
How Arbitel Trio 25 Tablet ER 15s works
Cilnidipine works by relaxing the blood vessels, making it easier for blood to flow through them, which helps lower blood pressure. Metoprolol Succinate is a beta-blocker that reduces the heart rate, helping the heart to pump blood more efficiently. Telmisartan is an angiotensin receptor blocker that prevents blood vessels from narrowing, further aiding in blood pressure reduction.
How To Use Arbitel Trio 25 Tablet ER 15s
- Take the tablet as prescribed by your doctor.
- Swallow it whole with water, preferably with food.
- Try to take it at the same time each day to maintain consistent blood levels.
- Do not crush or chew the tablet.
Special Precautions for Arbitel Trio 25 Tablet ER 15s
- Avoid alcohol as it can increase the risk of side effects.
- Inform your doctor if you have liver or kidney issues before starting the medication.
- Pregnant or breastfeeding women should consult their doctor before use.
- Do not stop taking the medication suddenly without consulting your doctor.
Benefits Of Arbitel Trio 25 Tablet ER 15s
- Helps in effectively lowering high blood pressure.
- Reduces the risk of heart attacks and strokes.
- Improves overall heart health by easing blood flow.
- Combines three medications for enhanced effectiveness.
Side Effects Of Arbitel Trio 25 Tablet ER 15s
- Common side effects include nausea, taste changes, and dizziness.
- Some may experience ankle swelling and a slow heart rate.
- Serious side effects can include severe dizziness or fainting.
- Consult a doctor if you experience persistent or severe side effects.
Health And Lifestyle
Written By
Yogesh Patil
M Pharma (Pharmaceutics)
Content Updated on
Wednesday, 10 January, 2024









